Literature DB >> 23086359

Deep intrastromal injection of bevacizumab for the management of corneal neovascularization.

Mehrdad Mohammadpour.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23086359     DOI: 10.1097/ICO.0b013e318262e872

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


× No keyword cloud information.
  6 in total

1.  Intrastromal bevacizumab in the management of corneal neovascularization: a retrospective review.

Authors:  Archana A Gupta; Danny A Mammo; Michael A Page
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-12       Impact factor: 3.117

Review 2.  New Therapeutic Perceptions in a Patient with Complicated Herpes Simplex Virus 1 Keratitis: A Case Report and Review of the Literature.

Authors:  Dimitrios Kalogeropoulos; Aliki Geka; Konstantinos Malamos; Maria Kanari; Chris Kalogeropoulos
Journal:  Am J Case Rep       Date:  2017-12-27

3.  Prophylactic effect of topical silica nanoparticles as a novel antineovascularization agent for inhibiting corneal neovascularization following chemical burn.

Authors:  Mehrdad Mohammadpour; Mahmoud Jabbarvand; Hassan Hashemi; Elham Delrish
Journal:  Adv Biomed Res       Date:  2015-06-04

4.  Combined intracorneal and subconjunctival bevacizumab injections for recurrent visual loss and intraocular hemorrhage from vascularized fibrous downgrowth.

Authors:  Ahmad M Mansour
Journal:  Case Rep Ophthalmol       Date:  2014-01-15

5.  Long-term Outcomes of Amniotic Membrane Transplantation in Contact Lens-Induced Pseudomonas Keratitis with Impending Corneal Perforation.

Authors:  Mehrdad Mohammadpour; Fatemeh Alsadat Sabet
Journal:  J Ophthalmic Vis Res       Date:  2016 Jan-Mar

6.  Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes.

Authors:  Belghmaidi Sarah; Hajji Ibtissam; Baali Mohammed; Soummane Hasna; Moutaouakil Abdeljalil
Journal:  J Ophthalmol       Date:  2016-08-17       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.